Previous 10 | Next 10 |
Kintara Therapeutics Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement PR Newswire SAN DIEGO , Dec. 5, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a bi...
2023-11-14 01:34:50 ET More on Kintara Therapeutics Kintara slumps on late-stage setback for tumor candidate Seeking Alpha’s Quant Rating on Kintara Therapeutics Historical earnings data for Kintara Therapeutics Financial information for Kintara Therap...
Kintara Therapeutics Announces Fiscal 2024 First Quarter Financial Results and Provides Corporate Update PR Newswire SAN DIEGO , Nov. 13, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company ...
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Kintara Therapeutics Inc. (KTRA) is expected to report for Q1 2024
2023-10-31 08:27:25 ET More on Kintara Seeking Alpha’s Quant Rating on Kintara Therapeutics Historical earnings data for Kintara Therapeutics Financial information for Kintara Therapeutics For further details see: Kintara announces late-stage setba...
Kintara Therapeutics Announces Preliminary Topline Results From GBM AGILE Study PR Newswire - VAL-083 Did Not Perform Better Than Current Standards of Care - - Company Suspending Development of VAL-083, Shifting Focus to REM-001 Program and Other Strategic Opportunitie...
Kintara Therapeutics to Present at the 8th Annual Dawson James Small Cap Growth Conference PR Newswire SAN DIEGO , Oct. 11, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the...
2023-10-04 16:52:20 ET More on Kintara Therapeutics Seeking Alpha’s Quant Rating on Kintara Therapeutics Historical earnings data for Kintara Therapeutics Financial information for Kintara Therapeutics For further details see: Kintara Therapeutics ...
Kintara Therapeutics to Present at the LD Micro Main Event XVI Conference PR Newswire SAN DIEGO , Oct. 2, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of ne...
News, Short Squeeze, Breakout and More Instantly...
Kintara Therapeutics Inc Com Company Name:
KTRA Stock Symbol:
NASDAQ Market:
Kintara Therapeutics Inc Com Website:
TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.'s KVA12123 Novel anti-VISTA Checkpoint Inhibitor PR Newswire KVA12123 is a rationally targeted, anti-VISTA antibody checkpoint inhibitor to reverse VISTA immune suppression and remod...
Kintara Therapeutics and TuHURA Biosciences Provide Update on Recent Corporate and Clinical Advancements and Outline Near Term Milestones PR Newswire SAN DIEGO , July 1, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara"), a biopharmaceutic...